Nipple-Sparing Mastectomy

A nipple-sparing mastectomy removes the breast tissue and keeps the skin, the nipple and the areola. The new breast is rebuilt in the same operation.

Nipple-sparing mastectomy treats early breast cancer and lowers the risk in women who carry a BRCA mutation. The surgeon removes all of the gland through a discreet incision, checks the tissue behind the nipple for cancer, and fills the skin envelope with an implant or with tissue from your own body. This page explains who qualifies, what ten years of data show on recurrence, how the nipple feels afterward, and what to send for a free review of your scans and biopsy.

What the operation keeps and removes

The breast gland comes out down to the chest muscle, while the skin, the nipple and the areola stay.

How it differs from other mastectomies

A skin-sparing mastectomy keeps the skin and removes the nipple. A simple mastectomy removes both, which leaves a flat chest and a long scar, and for many women the visible difference between those three operations matters as much in daily life as any figure on recurrence or survival.

Who is a candidate

Good candidates

• Early breast cancer at a distance from the nipple
• Ductal carcinoma in situ that needs a mastectomy
• A BRCA1, BRCA2 or other high-risk gene mutation, for risk reduction
• Small to medium breasts without marked sagging
• Non-smokers, or smokers who stop well before surgery

When the nipple cannot be kept

Cancer in the nipple itself, Paget disease of the nipple, bloody discharge from a cancer, inflammatory breast cancer and a tumor growing into the skin rule the operation out. Very large or sagging breasts raise the risk that the nipple loses its blood supply, and a reduction or lift beforehand sometimes solves that.

Tumors close to the nipple need a second look. Some suit breast-conserving surgery better.

In one cohort with such tumors, nipple numbness followed in 93.8 percent of women after this operation with implants and in 20.4 percent after breast-conserving surgery with reshaping.

Recurrence and survival

The worry is simple. Leaving the nipple could leave cancer cells behind. A review of 60 studies covering 7,752 women answered it with up to ten years of data. The data reassure. Against skin-sparing and modified radical mastectomy, local recurrence did not differ, and overall survival ran 2.1 percentage points higher after nipple-sparing surgery, a gap that reflects careful selection of the women offered it. Among the 391 women followed for ten years, cancer came back in the nipple in 1.1 percent.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

Risk-reducing surgery for BRCA carriers

In a Swedish national cohort of 1,208 women with a BRCA1 or BRCA2 mutation, breast cancer appeared at a rate of 2 per 10,000 person-years after risk-reducing mastectomy, against 162 per 10,000 in women who kept their breasts. Only one woman in the surgery group developed breast cancer, against 112 in the group without surgery, a contrast that families with a BRCA mutation weigh against what a mastectomy takes away, from feeling in the breast to the way the body looks and feels afterward. Hidden cancer turned up in 3.4 percent of the removed tissue, and complications sent 3.7 percent back to theater early.

Genetic counseling and a breast MRI come before any risk-reducing operation.

Reconstruction and the incision

Implant or your own tissue

Three in four women in the Swedish cohort chose implants, and 14.4 percent had their own tissue moved from the abdomen or elsewhere. Both work. An implant means a shorter operation and no second wound. Your own tissue needs no implant changes over the years and copes better with radiotherapy, at the cost of a longer operation and a longer stay.

Where the scar goes

In 290 conserving mastectomies at one Italian breast unit, an incision in the fold under the breast lowered the risk of nipple necrosis, while a Wise-pattern incision, the anchor-shaped cut used in breast reductions, raised it 3.6 times. Incisions around the areola carried more nipple and skin necrosis. Robotic and endoscopic approaches go further and hide a short cut at the side of the chest. Across 12 studies and 2,312 patients, the robotic approach had fewer overall and major complications than open surgery, with no difference in nipple necrosis or local recurrence, though it took longer.

On a phone, slide this table sideways to read all of its columns.

How the nipple feels afterward

Keeping the nipple keeps its look. Feeling is another matter.

A survey a median of six years after surgery with implants found that 57 percent of women described their nipples as totally numb and 32 percent as much less sensitive than before. Few kept normal feeling. Those with some feeling left scored higher for physical, emotional and sexual well-being on the BREAST-Q questionnaire. The table below sets out the full picture.

Drag sideways on a narrow screen to see the whole table.

Nerve grafting during reconstruction aims to bring some of it back. It helps. Among 132 women in a prospective study, those who received it scored higher on psychosocial well-being, 71.6 against 62.8, and on sexual well-being, 56.9 against 47.3.

The stay in Istanbul

One published Istanbul package for nipple-sparing mastectomy with implant reconstruction lists two nights in hospital and recommends one to two weeks in the city. Plan ten to fourteen days. That leaves time for the drains to come out and for the surgeon to go through the final pathology report with you, line by line, before you board the flight home.

1. Day one, examination, review of the breast MRI, blood tests and marking
2. Day two, surgery under general anesthesia
3. Days three to four, discharge with drains and a support bra
4. Days five to ten, drain removal and a wound check
5. Before the flight, the pathology report and a written plan for further treatment at home

A single coordinator answers on WhatsApp from your first message to your last check-up at home. Our coordinators speak English, Arabic, French, Russian, Serbian, Romanian and Spanish, and an interpreter covers other languages. A sister, mother or friend sleeps in your room on the companion bed. Airport transfers, the hotel booking before and after the stay and every ride to the hospital are arranged by the international patients office, and a female surgeon is assigned on request wherever the rota allows, so the practical side of the trip is settled before you land and the days in Istanbul go to healing. The kitchen cooks halal, vegetarian and diabetic meals. A prayer room is on site. Your visa invitation letter goes out ten days ahead. Drains and a fresh wound make a heavy bag hard to lift and a long queue tiring, so the coordinator arranges help with luggage and a wheelchair at both airports, and on the plane you walk the aisle every hour against clots. The final pathology goes to your oncologist at home in English, and the surgeon stays reachable by message for any question on the wound. Back home, follow-up continues by video call with the surgeon at two weeks and three months.

What the quote includes

Cost depends on one or both sides, implant or own-tissue reconstruction, the lymph node surgery and the nights in hospital, and a quote that names each of those items, along with the implant brand and the follow-up included after you fly home, is the only kind that compares fairly with another. The published package for this market lists these items.

• Surgery, anesthesia and the implant
• Tests and consultations before surgery
• The hospital stay, with a companion
• The first follow-up visit
• Airport and hospital transfers
• Translation of medical reports

Flights and the hotel are extra.

Nipple-sparing mastectomy FAQ

References

1. Rohrich RN, Soltani H, Snee I, Fan KL, Lesnikoski BA, De La Cruz LM. A decade later: an updated systematic review and meta-analysis of overall survival, disease-free survival, local recurrence, and nipple-areolar recurrence following nipple-sparing mastectomy. Ann Surg Oncol. 2026;33(12):10504-10521.
2. Wiberg R, Hagglund S, Numan Hellquist B, et al. Surgical outcomes after risk-reducing mastectomy among BRCA1 and BRCA2 carriers. JAMA Netw Open. 2026;9(4):e262574.
3. Huang JH, Xu RH, Xu JZ, et al. Comparison of quality of life and complications after oncoplastic breast-conserving surgery and implant-based reconstruction for central breast cancer, a retrospective cohort study. Gland Surg. 2026;15(4):86.
4. Vanni G, Pellicciaro M, Materazzo M, et al. Impact of incision type in breast cancer-conserving mastectomy: a comparative analysis of outcome. Updates Surg. 2025. doi:10.1007/s13304-025-02443-3.
5. Wang Z, Wu H, Chen F, Hou M, Li Z. Robotic versus conventional nipple-sparing mastectomy in early breast cancer: a systematic review and meta-analysis. BMC Surg. 2026;26(1). doi:10.1186/s12893-026-03799-y.
6. Hammond JB, Kandi LA, Armstrong VL, et al. Long-term breast and nipple sensation after nipple-sparing mastectomy with implant reconstruction: relevance to physical, psychosocial, and sexual well-being. J Plast Reconstr Aesthet Surg. 2022;75(9):2914-2919.
7. Shyu S, Chang TN, Lu JC, et al. Breast neurotization along with breast reconstruction after nipple sparing mastectomy enhances quality of life and reduces denervation symptoms in patient-reported outcome: a prospective cohort study. Int J Surg. 2025;111(5):3235-3247.